MYLAN-AZITHROMYCIN DIN 02278359
Status: Cancelled Post Market
Holder: MYLAN PHARMACEUTICALS ULC
Health Canada record
| Active ingredient(s) | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01FA10 AZITHROMYCIN |
| Original market date | 04-May-2006 |
| Current status date | 09-Mar-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Mylan Pharmaceuticals ULC — licence 101774, currently licensed, last inspection rating C (2026-02-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02267845 | TEVA-AZITHROMYCIN | TEVA CANADA LIMITED | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG | Marketed |
| 02363364 | AVA-AZITHROMYCIN | AVANSTRA INC | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG | Cancelled Post Market |
| 02282429 | DOM-AZITHROMYCIN | DOMINION PHARMACAL | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 100 MG | Cancelled Pre Market |
| 02278499 | DOM-AZITHROMYCIN | DOMINION PHARMACAL | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG | Cancelled Post Market |
| 02278502 | DOM-AZITHROMYCIN | DOMINION PHARMACAL | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 600 MG | Cancelled Post Market |
| 02282437 | DOM-AZITHROMYCIN | DOMINION PHARMACAL | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 200 MG | Cancelled Pre Market |
| 02315165 | NOVO-AZITHROMYCIN PEDIATRIC | TEVA CANADA LIMITED | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 200 MG | Cancelled Post Market |
| 02315157 | NOVO-AZITHROMYCIN PEDIATRIC | TEVA CANADA LIMITED | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 100 MG | Cancelled Post Market |
| 02282410 | PHL-AZITHROMYCIN | PHARMEL INC | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 200 MG | Cancelled Post Market |
| 02278596 | PHL-AZITHROMYCIN | PHARMEL INC | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 600 MG | Cancelled Pre Market |
| 02278588 | PHL-AZITHROMYCIN | PHARMEL INC | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG | Cancelled Post Market |
| 02282380 | PHL-AZITHROMYCIN | PHARMEL INC | Powder For Suspension | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 100 MG | Cancelled Post Market |
| 02275287 | RATIO AZITHROMYCIN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 250 MG | Cancelled Post Market |
| 02270358 | SANDOZ AZITHROMYCIN | SANDOZ CANADA INCORPORATED | Tablet | AZITHROMYCIN (AZITHROMYCIN MONOHYDRATE HEMIETHANOLATE) 500 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10521 | 2009-08-20 | Abbreviated New Drug Submission (ANDS) | Manufacturer and product name change |
| 7913 | 2006-05-01 | Abbreviated New Drug Submission (ANDS) | NEW MANUFACTURER AND PRODUCT NAME |